These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 28522373

  • 1. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients.
    Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O.
    Eur J Pharm Sci; 2017 Nov 15; 109S():S108-S115. PubMed ID: 28522373
    [Abstract] [Full Text] [Related]

  • 2. Effects of Type 2 Diabetes Mellitus in Patients on Treatment With Glibenclamide and Metformin on Carvedilol Enantiomers Metabolism.
    Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL.
    J Clin Pharmacol; 2017 Jun 15; 57(6):760-769. PubMed ID: 28114735
    [Abstract] [Full Text] [Related]

  • 3. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: Application to a clinical pharmacokinetic study.
    Nardotto GHB, Coelho EB, Marques MP, Lanchote VL.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar 15; 1015-1016():173-180. PubMed ID: 26927877
    [Abstract] [Full Text] [Related]

  • 4. Stereoselective disposition of carvedilol is determined by CYP2D6.
    Zhou HH, Wood AJ.
    Clin Pharmacol Ther; 1995 May 15; 57(5):518-24. PubMed ID: 7768074
    [Abstract] [Full Text] [Related]

  • 5. Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound.
    Neugebauer G, Akpan W, Kaufmann B, Reiff K.
    Eur J Clin Pharmacol; 1990 May 15; 38 Suppl 2():S108-11. PubMed ID: 1974498
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction.
    Neugebauer G, Gabor M, Reiff K.
    J Cardiovasc Pharmacol; 1992 May 15; 19 Suppl 1():S142-6. PubMed ID: 1378143
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multiple regression analysis of pharmacogenetic variability of carvedilol disposition in 54 healthy Japanese volunteers.
    Honda M, Ogura Y, Toyoda W, Taguchi M, Nozawa T, Inoue H, Hashimoto Y.
    Biol Pharm Bull; 2006 Apr 15; 29(4):772-8. PubMed ID: 16595916
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
    Fujimaki M.
    Drug Metab Dispos; 1994 Apr 15; 22(5):700-8. PubMed ID: 7835220
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.